ADAR1 Capital Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001940272

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q1 2026 · 295 positions · Total reported value $1.45B · Top-10 concentration 36.7% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 47.5% · 33 new · 62 cut · 48 exited

Active Share (vs S&P 500): 98.9% · vs QQQ: 99.4% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -7.0% · vs SPY -9.1% · Prev Value $1.81B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -3.7% · vs SPY -5.9% · Latest Value $1.82B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2026 13F filing, ADAR1 Capital Management, LLC disclosed 295 equity positions with a combined reported value of $1.45B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 36.7% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2026 were PTGX ($104.78M), ROIV ($91.02M), IMVT ($66.55M). By sector, the heaviest allocations are Health Care 83.6%, Financials 2.0%. Versus the prior quarter, allocation shifted toward Health Care (+4.2pp), Financials (+0.5pp) and away from Other (-4.7pp).

Versus the prior quarter, ADAR1 Capital Management, LLC opened 33 new positions, trimmed 62 and fully exited 48, a turnover rate of 47.5% of positions. The portfolio's overlap with the prior quarter was 70% of names.

The largest new positions opened in Q1 2026 were BEAM ($34.47M), VIR ($24.59M), DBVT ($21.16M).

Of the 48 positions fully exited versus the prior quarter, the largest were RNAM ($39.42M), RAPT ($17.26M), CDTX ($13.18M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • BEAM BEAM THERAPEUTICS INC · $34.47M
  • VIR VIR BIOTECHNOLOGY INC · $24.59M
  • DBVT DBV TECHNOLOGIES S A · $21.16M
  • HLXC HELIX ACQUISITION CORP III · $10.30M
  • MPLT MAPLIGHT THERAPEUTICS INC · $7.62M
  • DMRA DAMORA THERAPEUTICS INC · $7.23M
  • PRME PRIME MEDICINE INC · $6.87M
  • KRRO KORRO BIO INC · $6.11M

Fully Exited (vs previous quarter)

  • RNAM AVIDITY BI · prev qtr: $39.42M
  • RAPT RAPT THERAPEUTICS INC · prev qtr: $17.26M
  • CDTX CIDARA THERAPEUTICS INC · prev qtr: $13.18M
  • AAM AA MISSION · prev qtr: $4.32M
  • AVDL AVADEL PHARMACEUTICALS · prev qtr: $3.24M
  • BBOT BRIDGEBIO ONCOLOGY THERAPEUT · prev qtr: $2.83M
  • DVAX DYNAVAX TECHNOLOGIES CORP · prev qtr: $2.61M
  • ATXS ASTRIA THERAPEUTICS INC · prev qtr: $2.27M

Insider Transactions (Form 4)

Latest ADAR1 Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-11-11 Buy NextCure, Inc. 12,333 $5.10 SEC filing
2026-11-06 Buy NextCure, Inc. 3,662 $5.10 SEC filing
2026-11-05 Buy InMed Pharmaceuticals Inc. 2,640 $13.10 SEC filing
2026-11-05 Buy NextCure, Inc. 1,024 $5.10 SEC filing
2026-10-27 Buy NextCure, Inc. 3,553 $5.10 SEC filing
2026-10-26 Buy NextCure, Inc. 1,672 $5.03 SEC filing
2026-10-23 Buy InMed Pharmaceuticals Inc. 4 $1.32 SEC filing
2026-10-23 Buy NextCure, Inc. 5,626 $4.83 SEC filing

All insider transactions →

Fund Profile

ADAR1 Capital Management, LLC is an SEC-registered 13F filer based in Austin, TX, United States. As of Q2 2026 it reported 268 US equity positions with a combined value of $1.81B. HoldingsHub carries 11 quarters of its filings (Q4 2023–Q2 2026).

Firm Snapshot

  • Headquarters: AUSTIN, TX, United States
  • SEC registration: 801-130082 (status: Approved), registered 2024-04-25
  • Regulatory AUM (Form ADV): $1.68B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds

Portfolio Structure

  • 268 positions · $1.81B reported value (Q2 2026)
  • Top 10 holdings = 34.2% of reported value
  • Largest position: PTGX (PROTAGONIST THERAPEUTICS INC) at 6.5%
  • Average position size: $6.74M

Sector Tilt

  • Health Care 86.5%
  • Financials 2.6%
  • Industrials 0.4%
  • (classified holdings cover 90% of value)

Quarterly Activity

  • Q2 2026: 42 new, 99 added, 60 reduced, 69 exited
  • 67 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 83.6%
Financials 2.0%
Technology 0.1%
Other 13.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 994.12K $104.78M 7.25%
7.25%
Reduce
2 3.29M $91.02M 6.29%
6.29%
Reduce
3 2.68M $66.55M 4.60%
4.60%
Add
4 75.94K $49.39M 3.42%
3.42%
Add
5 632.56K $41.69M 2.88%
2.88%
Add
6 1.14M $41.38M 2.86%
2.86%
Add
7 337.12K $39.20M 2.71%
2.71%
Hold
8 1.87M $35.93M 2.48%
2.48%
Add
9 1.45M $34.47M 2.38%
2.38%
New
10 1.43M $26.81M 1.85%
1.85%
Add
11 1.09M $26.19M 1.81%
1.81%
Reduce
12 2.74M $24.59M 1.70%
1.70%
New
13 1.01M $21.16M 1.46%
1.46%
New
14 3.79M $21.03M 1.45%
1.45%
Add
15 405.20K $20.90M 1.45%
1.45%
Add
16 407.27K $20.02M 1.39%
1.39%
Add
17 211.45K $18.39M 1.27%
1.27%
Add
18 338.32K $17.07M 1.18%
1.18%
Add
19 3.41M $16.03M 1.11%
1.11%
Add
20 1.58M $15.37M 1.06%
1.06%
Add
21 316.94K $15.27M 1.06%
1.06%
Add
22 259.14K $15.06M 1.04%
1.04%
Reduce
23 264.28K $14.48M 1.00%
1.00%
Add
24 3.13M $14.10M 0.97%
0.97%
Reduce
25 1.00M $13.91M 0.96%
0.96%
Add
26 427.82K $13.57M 0.94%
0.94%
Reduce
27 2.98M $13.32M 0.92%
0.92%
Add
28 228.90K $13.31M 0.92%
0.92%
Add
29 524.44K $13.06M 0.90%
0.90%
Add
30 133.89K $13.02M 0.90%
0.90%
Reduce
31 329.54K $12.92M 0.89%
0.89%
Add
32 185.70K $12.57M 0.87%
0.87%
Reduce
33 135.59K $12.43M 0.86%
0.86%
Hold
34 213.47K $12.12M 0.84%
0.84%
Add
35 2.17M $12.07M 0.83%
0.83%
Reduce
36 160.34K $12.04M 0.83%
0.83%
Add
37 161.25K $11.60M 0.80%
0.80%
Add
38 6.61M $11.10M 0.77%
0.77%
Reduce
39 1.36M $10.93M 0.76%
0.76%
Add
40 200.00K $10.54M 0.73%
0.73%
Reduce
41 1.00M $10.30M 0.71%
0.71%
New
42 4.54M $10.09M 0.70%
0.70%
Add
43 2.43M $10.08M 0.70%
0.70%
Add
44 12.15K $9.39M 0.65%
0.65%
Add
45 1.47M $8.42M 0.58%
0.58%
Add
46 1.85M $8.41M 0.58%
0.58%
Add
47 268.39K $8.08M 0.56%
0.56%
Add
48 1.46M $8.00M 0.55%
0.55%
Add
49 374.91K $7.62M 0.53%
0.53%
New
50 727.48K $7.48M 0.52%
0.52%
Add

FAQ

What did ADAR1 Capital Management, LLC buy in 2026-Q1?

In its 2026-Q1 13F filing, ADAR1 Capital Management, LLC reported 295 equity positions worth $1.45B in aggregate; its largest disclosed positions were PTGX ($104.78M), ROIV ($91.02M), IMVT ($66.55M).

How large is ADAR1 Capital Management, LLC's portfolio?

ADAR1 Capital Management, LLC reported $1.45B of long equity holdings across 295 positions as of 2026-Q1. Top-10 holdings account for 36.7% of reported value.

What is ADAR1 Capital Management, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/adar1-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →